Yunfeng, Co-Win Leads $32M Series B In Huakang Mobile Health

Investment Research Team
April 28, 2015 — 14:55 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: Alibaba chinese guangdong healthcare Henan investment Jack Ma medicine mobile mobile internet new horizon capital news media online shopping shenzhen venture capital

Related News:

China’s Nvidia Contender Cambricon Tech Struggles To Push Chinese-Made AI Chips as It Marks 7th Consecutive Year of Losses

February 9, 2024 — 10:25

ByteDance Is Undervalued: TikTok’s Parent Could Be Worth More Than Tencent and Possibly Meta

January 11, 2024 — 01:33

China To Expand Investment Scope for Its National Social Security Fund

December 8, 2023 — 00:03

DealShot: 14 Deals Eclipsing $800 Million With CICC Capital, Shenzhen Capital Group And More

September 28, 2022 — 16:54

US’s Top 10 Public Companies Worth Over Five Times Than China’s Top 10

December 21, 2021 — 23:37

China Tech Digest: Tencent Unveils Three Self-developed Chips; Huawei’s Autonomous Driving Unit Founder Joins Zeekr

November 4, 2021 — 09:39

Honda China Collaborates with AutoX on Autonomous Driving Research Through Testing on China’s Public Roads

April 16, 2021 — 21:49

China’s Beidou Satellite System Finds Another Application: Sending Early Warnings For Landslide

March 3, 2021 — 03:17

China, With 1.4 Billion People, Faces Looming Demographic Crisis

February 18, 2021 — 04:48

Franchising and Licensing Asia (FLAsia) 2024